Insider Transactions last 24 months for AN2 Therapeutics, Inc.  -  NSDQ: ANTX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Martin Patricia A.Director07/10/2025AADirectCOM3,750$0.00$0.009,981
Marks Gilbert LynnDirector07/10/2025AADirectCOM11,875$0.00$0.0053,382
Aziz KabeerDirector07/10/2025AADirectCOM11,875$0.00$0.0030,552
Easom EricChief Executive Officer06/02/2025APDirectCOM10,000$1.07$10,665.00256,380
Leonard Braden MichaelOther05/30/2025DSIndirectCOM7,000$1.03$7,226.803,217,432
Leonard Braden MichaelOther05/30/2025DSIndirectCOM425,000$1.01$429,250.003,224,432
Fitzpatrick Margaret MDirector05/28/2025APDirectCOM8,610$1.18$10,133.118,610
Leonard Braden MichaelOther05/28/2025DSIndirectCOM100,000$1.16$116,000.003,649,432
Leonard Braden MichaelOther05/28/2025DSIndirectCOM2,000,000$1.16$2,320,000.003,749,432
Leonard Braden MichaelOther05/28/2025DSIndirectCOM200,000$1.09$218,000.003,017,432
Marks Gilbert LynnDirector04/10/2025AADirectCOM9,705$0.00$0.0041,507
Martin Patricia A.Director04/10/2025AADirectCOM3,065$0.00$0.006,231
Aziz KabeerDirector04/10/2025AADirectCOM9,705$0.00$0.0018,677
Zakrzewski Joseph SDirector04/10/2025AADirectCOM10,523$0.00$0.00145,538
Prior Stephen DavidChief Strategy Officer02/26/2025AADirectCOM28,000$0.00$0.0061,313
Easom EricChief Executive Officer02/26/2025AADirectCOM145,250$0.00$0.00246,380
Eizen Joshua MSee Remarks02/26/2025AADirectCOM58,500$0.00$0.00175,172
Day LucyChief Financial Officer02/26/2025AADirectCOM46,500$0.00$0.0079,170
Chanda SanjayChief Development Officer02/26/2025AADirectCOM50,250$0.00$0.0080,074
Readnour Robin ShaneDirector12/19/2024AADirectCOM9,077$0.00$0.009,077
Zakrzewski Joseph SDirector12/19/2024AADirectCOM9,816$0.00$0.00135,015
Marks Gilbert LynnDirector12/19/2024AADirectCOM8,972$0.00$0.0031,802
Aziz KabeerDirector12/19/2024AADirectCOM8,972$0.00$0.008,972
Martin Patricia A.Director12/19/2024AADirectCOM3,166$0.00$0.003,166
Zakrzewski Joseph SDirector11/27/2024APDirectCOM2,000$1.40$2,800.00125,199
1   2  3  4  Next Last  You are at page 1 of 4 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel